Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Early cervical cancer and fertility-sparing surgery, drawn from the whole corpus: 5 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
Whether sentinel node biopsy alone can replace lymphadenectomy (SENTICOL III).
Safe fertility-sparing options for tumours of two to four centimetres.
Why minimally invasive surgery did harm, and whether protective techniques can restore it.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 9 changes by month →When this page itself was last checked or edited.
Simple hysterectomy was non-inferior to radical hysterectomy for three-year pelvic recurrence in low-risk early cervical cancer, with fewer urinary complications.
A milestone in how this cancer is treated.
4.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.